Specify a stock or a cryptocurrency in the search bar to get a summary
Strides Pharma Science Limited
STARStrides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India. Address: Strides House, Bengaluru, India, 560076
Analytics
WallStreet Target Price
158 475.75 INRP/E ratio
80Dividend Yield
0.18 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures STAR
Dividend Analytics STAR
Dividend growth over 5 years
-25 %Continuous growth
1 yearPayout Ratio 5 years average
23 %Dividend History STAR
Stock Valuation STAR
Financials STAR
Results | 2019 | Dynamics |